Agentix AGTX
OTC AGTX
$0.02 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Agentix (AGTX) Assets (2014 - 2026)

Agentix's (AGTX) quarterly Assets came in at $771.0 in Q1 2026, down 99.23% YoY from $100274.0 in Q1 2025, and down 87.95% on a QoQ basis from $6396.0 in Q4 2025.

Agentix (AGTX) Assets (2014 - 2026) Analysis & Trends

Agentix (AGTX) has 13 years of Assets data on file, last reported at $771.0 in Q1 2026.

  • Quarterly Assets fell 99.23% year-over-year to $771.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $771.0 (down 99.23% YoY) and the FY2026 annual result came in at $771.0, down 99.23% from the prior year.
  • Assets eased to $771.0 in Q1 2026, from $6396.0 in the prior quarter.
  • In the past five years, Assets ranged from a high of $333704.0 in Q3 2023 to a low of $771.0 in Q1 2026.
  • A 5-year average of $114772.7 and a median of $106372.0 in 2024 frame the typical range for Assets.
  • Annual changes were most pronounced in 2023 — Assets jumped 3809.83% — and 2026, when it sank 99.23%.
  • Tracing AGTX's Assets over 5 years: stood at $111475.0 in 2022, then grew by 0.43% to $111951.0 in 2023, then surged by 37.66% to $154111.0 in 2024, then slumped by 95.85% to $6396.0 in 2025, then slumped by 87.95% to $771.0 in 2026.
  • The last three Assets figures came in at $771.0 (Q1 2026), $6396.0 (Q4 2025), and $5601.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 138.90 Bn 131.05 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 86.10 Bn 78.11 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 65.56 Bn 60.37 Bn 1.37 Bn 10.03 Bn
4 Moderna 55.82 Bn 50.68 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 42.14 Bn 37.04 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.38 Bn 26.54 Bn - 19.82 Bn
10 Agentix 801,339.00 801,301.00 - 38.00

Historic Data

Download Data
DateValue
Jun 30, 2026 38.00
Mar 31, 2026 771.00
Dec 31, 2025 6,396.00
Sep 30, 2025 5,601.00
Jun 30, 2025 4,412.00
Mar 31, 2025 100,274.00
Dec 31, 2024 154,111.00
Sep 30, 2024 169,960.00
Jun 30, 2024 166,946.00
Mar 31, 2024 106,372.00
Dec 31, 2023 111,951.00
Sep 30, 2023 333,704.00
Jun 30, 2023 330,500.00
Mar 31, 2023 261,392.00
Dec 31, 2022 111,475.00
Sep 30, 2022 8,535.00
Jun 30, 2022 11,022.00
Feb 28, 2022 67,714.00
Nov 30, 2021 50,676.00
Aug 31, 2021 51,207.00